JUJürgen Unützer

Jürgen Unützer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jürgen Unützer has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Wayne Katon

    Department of Psychiatry, University of Washington, Seattle, Washington

    6 shared publications
  • Lingqi Tang

    4 shared publications
  • Christopher M. Callahan

    Indiana University Center for Aging Research, Regenstrief Institute for Health Care, Indianapolis, Indiana

    3 shared publications
  • Linda Harpole

    Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center and Duke University Medical Center, Durham, North Carolina

    3 shared publications
  • Marc Hoffing

    Desert Medical Group, Palm Springs, California

    3 shared publications
  • Donald L. Patrick

    Department of Health Services, University of Washington. Seattle, WA

    2 shared publications

Latest Publications

  • Comparison of Psychiatrists' and Other Physicians' Assessments of Their Ability to Deliver High-Quality Care

    by Mark J. Edlund, Thomas R. Belin, Lingqi Tang, Diana Liao, Jürgen Unützer

    This study compared psychiatrists' assessments of their ability to deliver high-quality care with those of other physicians. Data were used from the Community Tracking Study Physician Survey, a national survey of 12,528 physicians. Linear regression models were used to investigate the effects of type of physician (psychiatrist or other physician), managed care involvement, and ability to obtain inpatient care on four measures of physicians' assessments of quality. In models that did not control for difficulty in obtaining inpatient services, assessments of quality were significantly lower among psychiatrists than among other physicians. Furthermore, although managed care involvement was associated with lower assessments of quality for all physicians in these models, the effects were stronger for psychiatrists than for other physicians. However, after difficulty in obtaining inpatient services was controlled for, psychiatrists' and other physicians' assessments of quality were similar. Compared with other physicians, psychiatrists' assessments of the quality of care that they provide were lower and their assessments were more influenced by involvement with managed care. These differences may be mediated by difficulty in obtaining inpatient services. When designing and administering behavioral health benefits packages, clinical policy makers should consider the possible effects of reduction in inpatient services on quality of care.


  • Depression Treatment in a Sample of 1,801 Depressed Older Adults in Primary Care

    by Jürgen Unützer, Wayne Katon, Christopher M. Callahan, Mhs John W. Williams Jr. Md, Enid Hunkeler Ma, Linda Harpole, Marc Hoffing, Richard D. Della Penna, Polly Hitchcock Noel, Elizabeth H. B. Lin, et al.

    OBJECTIVES: To examine rates and predictors of lifetime and recent depression treatment in a sample of 1,801 depressed older primary care patients DESIGN: Cross sectional survey data collected from 1999 to 2001 as part of a treatment effectiveness trial. SETTING: Eighteen primary care clinics belonging to eight organizations in five states. PARTICIPANTS: One thousand eight hundred one clinic users aged 60 and older who met diagnostic criteria for major depression or dysthymia. MEASUREMENTS: Lifetime depression treatment was defined as ever having received a prescription medication, counseling, or psychotherapy for depression. Potentially effective recent depression treatment was defined as 2 or more months of antidepressant medications or four or more sessions of counseling or psychotherapy for depression in the past 3 months. RESULTS: The mean age ± standard deviation was 71.2 ± 7.5; 65% of subjects were women. Twenty‐three percent of the sample came from ethnic minority groups (12% were African American, 8% were Latino, and 3% belonged to other ethnic minorities). The median household income was $23,000. Most study participants (83%) reported depressive symptoms for 2 or more years, and most (71%) reported two or more prior depressive episodes. About 65% reported any lifetime depression treatment, and 46% reported some depression treatment in the past 3 months, although only 29% reported potentially effective recent depression treatment. Most of the treatment provided consisted of antidepressant medications, with newer antidepressants such as selective serotonin reuptake inhibitors constituting the majority (78%) of antidepressants used. Most participants indicated a preference for counseling or psychotherapy over antidepressant medications, but only 8% had received such treatment in the past 3 months, and only 1% reported four or more sessions of counseling. Men, African Americans, Latinos, those without two or more prior episodes of depression, and those who preferred counseling to antidepressant medications reported significantly lower rates of depression care. CONCLUSION: The findings suggest that there is considerable opportunity to improve care for older adults with depression. Particular efforts should be focused on improving access to depression care for older men, African Americans, Latinos, and patients who prefer treatments other than antidepressants.


  • Top Cited Papers
    Open Access

    Collaborative Care Management of Late-Life Depression in the Primary Care Setting

    by Jürgen Unützer, Wayne Katon, Christopher M. Callahan, Jr John W. Williams, Enid Hunkeler, Linda Harpole, Marc Hoffing, Richard D. Della Penna, Polly Hitchcock Noël, Elizabeth H. B. Lin, et al.

    Major depression and dysthymic disorder affect between 5% and 10% of older adults seen in the primary care setting.1-3 Late-life depression is often chronic or recurrent4-8 and is associated with substantial suffering, functional impairment, and diminished health-related quality of life.9 Depressed, older primary care patients are frequent users of general medical services5,10-12 and may have poor adherence to medical treatments.13 They are also at increased risk of death from suicide14 and medical illnesses.15-17 Although late-life depression can be successfully treated with antidepressant medications or psychotherapy,18-21 few depressed older adults receive adequate trials of such treatments in primary care22-28 or see a mental health specialist.25,29-35 Efforts to improve late-life depression treatment using screening and health care practitioner feedback and education have not resulted in consistent improvements in depression.22,23 A more comprehensive intervention strategy may be needed to improve outcomes for this population.


  • Depressive Symptoms and Mortality in a Prospective Study of 2,558 Older Adults

    by Jürgen Unützer, Donald L. Patrick, Tonya Marmon, Gregory E. Simon, Wayne J. Katon


  • Open Access

    Two-Year Effects of Quality Improvement Programs on Medication Management for Depression

    by Jürgen Unützer, Lisa Rubenstein, Wayne J. Katon, Lingqi Tang, Naihua Duan, Isabel T. Lagomasino, Kenneth B. Wells

    DEPRESSION is a major cause of disability worldwide1 and is common in primary care.2,3 Despite dissemination of practice guidelines for depression,4-6 significant underuse of evidence-based treatments for depression persists in primary care.7,8 Quality improvement (QI) efforts in primary care have been shown to increase rates of care and clinical outcomes for major depression for up to 8 months,9-12 but improvements in care were not sustained at longer-term follow-ups.13,14 We describe the impact of 2 QI interventions on the use of antidepressant medications and minor tranquilizers over 2 years.


  • Improving Primary Care for Depression in Late Life: The Design of a Multicenter Randomized Trial

    by Jürgen Unützer, Wayne Katon, John W. Williams, Christopher M. Callahan, Linda Harpole, Enid M. Hunkeler, Marc Hoffing, Patricia Arean, Mark T. Hegel, Michael Schoenbaum, et al.

    Late life depression can be successfully treated with antidepressant medications or psychotherapy, but few depressed older adults receive effective treatment. A randomized controlled trial of a disease management program for late life depression. Approximately 1,750 older adults with major depression or dysthymia are recruited from seven national study sites. Half of the subjects are randomly assigned to a collaborative care program where a depression clinical specialist supervised by a psychiatrist and a primary care expert supports the patient’s regular primary care provider to treat depression. Intervention services are provided for 12 months using antidepressant medications and Problem Solving Treatment in Primary Care according to a stepped care protocol that varies intervention intensity according to clinical needs. The other half of the subjects are assigned to care as usual. Subjects are independently assessed at baseline, 3 months, 6 months, 12 months, 18 months, and 24 months. The evaluation assesses the incremental cost-effectiveness of the intervention compared with care as usual. Specific outcomes examined include care for depression, depressive symptoms, health-related quality of life, satisfaction with depression care, health care costs, patient time costs, market and nonmarket productivity, and household income. The study blends methods from health services and clinical research in an effort to protect internal validity while maximizing the generalizability of results to diverse health care systems. We hope that this study will show the cost-effectiveness of a new model of care for late life depression that can be applied in a range of primary care settings.


  • Top Cited Papers

    Mental Disorders and the Use of Alternative Medicine: Results From a National Survey

    by Jürgen Unützer, Ruth Klap, Roland Sturm, Alexander S. Young, Tonya Marmon, Jess Shatkin, Kenneth B. Wells

    OBJECTIVE: The study examined the relationship between mental disorders and the use of complementary and alternative medicine. METHOD: Data from a national household telephone survey conducted in 1997–1998 (N=9,585) were used to examine the relationships between use of complementary and alternative medicine during the past 12 months and several demographic variables and indicators of mental disorders. Structured diagnostic screening interviews were used to establish diagnoses of probable mental disorders. RESULTS: Use of complementary and alternative medicine during the past 12 months was reported by 16.5% of the respondents. Of those respondents, 21.3% met diagnostic criteria for one or more mental disorders, compared to 12.8% of respondents who did not report use of alternative medicine. Individuals with panic disorder and major depression were significantly more likely to use alternative medicine than those without those disorders. Respondents with mental disorders who reported use of alternative medic...


  • Open Access

    Quality Adjusted Life Years in Older Adults With Depressive Symptoms and Chronic Medical Disorders

    by Jürgen Unützer, Donald L. Patrick, Paula Diehr, Greg Simon, David Grembowski, Wayne Katon


  • Treating Depressed Older Adults in Primary Care: Narrowing the Gap between Efficacy and Effectiveness

    by Jürgen Unützer, Wayne Katon, Mark Sullivan, Jeanne Miranda

    There is a gap between the efficacy of treatments for late‐life depression under research conditions and the effectiveness of treatments as they occur in the “real world” of primary care. Considerable evidence supports the efficacy of treatments for late‐life depression, but many depressed older adults either are not recognized or do not receive effective treatment for depression in primary care. Older adults face a range of special treatment barriers: knowledge deficits; losses and social isolation; multiple medical problems; and lack of financial resources. More research is needed to understand these barriers and to study the effectiveness of multifaceted, population‐based disease management interventions for late‐life depression in primary care.